Brendan Pierson
3 minute read
An employee uses an electrocardiogram function on a Fitbit smartwatch at the IFA consumer technology fair, amid the coronavirus disease (COVID-19) outbreak, in Berlin, Germany September 3, 2020. Availability of ECG app pending applicable regulatory clearances including approval under Directive 93/42/EEC (the Medical Device Directive). REUTERS/Michele Tantussi/File Photo
A Missouri man suing Zimmer Biomet Holdings Inc alleging that he suffered long-term injuries as a result of a hip implant made by the company must turn over data from his Fitbit fitness tracking device following surgery to remove the implant, a federal judge has ruled.
U.S. District Judge John Ross in the Eastern District of Missouri ruled Monday that the data from the device, which tracks number of steps, heart rate and sleep, was potentially relevant to whether or not plaintiff Guan Hollins suffered the injuries he alleges.
Legal Allergan loses bid to escape New York opioid trial
Brendan Pierson
5 minute read
A sign marks Allergan s offices in Medford, Massachusetts, U.S., July 31, 2017. REUTERS/Brian Snyder
AbbVie Inc s Allergan Finance LLC unit will face trial alongside a slew of drugmakers, distributors and pharmacies over claims by New York s attorney general and two counties that it fueled an opioid addiction crisis, a New York judge has ruled.
Suffolk County Supreme Court Justice Jerry Garguilo on Monday denied Allergan s motion to be severed from the June 22 trial, rejecting its argument that it should not be lumped with other defendants because it accounted for a very small share of the opioid market.